Navigation Links
Hands-On Treatment Improves Chronic Low Back Pain, Reduces Medication Use
Date:3/18/2013

FORT WORTH, Texas, March 18, 2013 /PRNewswire-USNewswire/ -- The numbers are staggering. More than 632 million people worldwide suffer from low back pain, and it is a leading cause of disability. According to the Institute of Medicine, one-third of all Americans suffer from chronic pain, which exceeds the number of people who are affected by heart disease, diabetes and cancer combined.

In the U.S., approximately 100 million adults are affected by chronic pain, and the economic costs of Medical care and lost productivity total more than $550 billion annually.

"Chronic low back pain is an important component of these costs," said John Licciardone , D.O. and executive director of The Osteopathic Research Center at the UNT Health Science Center in Fort Worth (UNTHSC) and author of a study published today in the Annals of Family Medicine. "Our research offers hope in the form of a hands-on treatment that provides moderate to substantial improvement in pain, and that reduces the use of prescription medication."

This study, conducted at UNTHSC used osteopathic manual treatment (OMT) and ultrasound therapy to treat chronic low back pain in 455 adults. Patients in the study who received ultrasound therapy did not see any improvement, but the patients who received OMT saw significant improvement in pain, used less prescription medication and were more satisfied with their care over the 12 weeks of the study than those patients who did not receive OMT.

In study patients who received OMT, nearly two-thirds had a 30-percent reduction in their pain  level, and half had a 50-percent reduction in their pain level. Patients received six treatments during the course of the study.

"One of the great benefits of OMT is that it has few side effects compared with other common treatments for low back pain that often involve serious side effects," Licciardone said. "In our study, patients who had higher levels of pain saw even greater reductions in pain. Not only does OMT reduce pain, it seems to work even better in people who experience higher pain levels. These are the people who are often treated with potentially addictive drugs such as OxyContin and Vicodin, epidural steroid injections or surgery.

If we can reduce the use of these drugs and invasive procedures by helping people to feel better with hands‐on treatment that has few side effects, that is a plus for our patients and contributes to the management of chronic pain."

This research was funded by the National Institutes of Health–National Center for Complementary and Alternative Medicine (K24--‐AT002422) and the Osteopathic Heritage Foundation.

The UNT Health Science Center comprises the Texas College of Osteopathic Medicine, Graduate School of Biomedical Sciences, School of Public Health, School of Health Professions and the UNT System College of Pharmacy (opening in fall 2013). Key research areas include aging and Alzheimer's disease, applied genetics, primary care and prevention.

In addition to its flagship school, the Texas College of Osteopathic Medicine, the UNT Health Science Center houses The Osteopathic Research Center, which is a leading research center in osteopathic medicine focusing on the effectiveness of OMT and other distinct aspects of osteopathic medical care.


'/>"/>
SOURCE UNT Health Science Center
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
3. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
4. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
5. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
6. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
7. National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
8. Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain
9. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
10. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
11. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2017)... June 19, 2017  Researchers from DRUGSCAN ® ... will host a live, complimentary webinar titled, "Untangling methods ... to the real world" on Wednesday June 28, 2017 ... This webinar will feature interviews with recreational and ... the manipulation techniques abusers use to prepare opioid tablets ...
(Date:6/16/2017)... years ago today, the Monterey Pop Festival opened its gates ... Francisco "Summer of Love."  To celebrate the anniversary, Northern Light® ... market research portals that it will begin delivering to customers ... "Summer of Love (For Our Customers)."  ... Northern Light ...
(Date:6/14/2017)... The Bio Supply Management Alliance (BSMA) has ... and the Biomedical Manufacturing Network to advance ... California by providing a platform for ... workforce development. The primary focus of this alliance is ... well as small and mid-sized biomedical companies. ...
Breaking Medicine Technology:
(Date:6/20/2017)... Murfreesboro, Tennessee (PRWEB) , ... June 20, 2017 ... ... chronic care services, announced today that Claritas Capital, a Nashville-based private equity firm, ... to accelerate our expansion plans for some time, and Claritas Capital offers the ...
(Date:6/20/2017)... York City (PRWEB) , ... June 20, 2017 , ... After months of negotiations, FaceCradle ... QVC Network on Wednesday, June 21. , “Introducing our product on QVC is ... for us to promote our travel pillow to more than 90 million homes in the ...
(Date:6/20/2017)... PA (PRWEB) , ... June 20, 2017 , ... Fresenius ... specialize in minimally invasive techniques to treat and manage a wide range of vascular ... strategic rebranding initiative. With more than 65 centers represented by more than 40 local ...
(Date:6/20/2017)... ... June 20, 2017 , ... HOUSTON – Brazos Towers at Bayou ... host of new options for today’s modern senior. Brazos Towers at Bayou Manor has ... they love while offering them the services to support that lifestyle both now and ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... Leading dental ... three-dimensional imaging technology with the VATECH PaX-i and Anatomage systems. With advanced digital images ... so they can place dental implants precisely and restore oral health for those who ...
Breaking Medicine News(10 mins):